Explore more publications!
Health Brief Somalia
Got News to Share?

Health Brief Somalia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Brief Somalia.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on January 5, 2026

Alumis to Host Conference Call and Webcast to Report Phase 3 ONWARD Topline Data for Envudeucitinib in Moderate-to-Severe Plaque Psoriasis
January 5, 2026

Alumis to Host Conference Call and Webcast to Report Phase 3 ONWARD Topline Data for Envudeucitinib in Moderate-to-Severe Plaque Psoriasis

Indeterminate GlobeNewswire
Integra LifeSciences Leadership to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 5, 2026

Integra LifeSciences Leadership to Present at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 5, 2026

Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Compass Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 5, 2026

Compass Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Teladoc Health to Participate in Upcoming Investor Conference
January 5, 2026

Teladoc Health to Participate in Upcoming Investor Conference

Indeterminate GlobeNewswire
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 5, 2026

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Bright Minds to Announce Topline Results for BMB-101 Phase 2 Trial in Absence Seizures and Developmental and Epileptic Encephalopathies on Tuesday, January 6, 2026
January 5, 2026

Bright Minds to Announce Topline Results for BMB-101 Phase 2 Trial in Absence Seizures and Developmental and Epileptic Encephalopathies on Tuesday, January 6, 2026

Indeterminate GlobeNewswire
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 5, 2026

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Enovis Appoints Oliver Engert as Chief Administrative Officer
January 5, 2026

Enovis Appoints Oliver Engert as Chief Administrative Officer

Indeterminate GlobeNewswire
Myriad Genetics to Present at 44th Annual J.P. Morgan Healthcare Conference
January 5, 2026

Myriad Genetics to Present at 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Outset Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 5, 2026

Outset Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
The Joint Corp. Appoints Ron Stilwell SVP Operations and Patient Experience
January 5, 2026

The Joint Corp. Appoints Ron Stilwell SVP Operations and Patient Experience

Indeterminate GlobeNewswire
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 5, 2026

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Heartflow to Participate in the 44th Annual J.P. Morgan Healthcare Conference
January 5, 2026

Heartflow to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
AVITA Medical Announces Changes to its Board of Directors
January 5, 2026

AVITA Medical Announces Changes to its Board of Directors

Indeterminate GlobeNewswire
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
January 5, 2026

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Citrus Burn Examined (URGENT REPORT) The Science Behind the Orange Peel Trick for Metabolic Support
January 5, 2026

Citrus Burn Examined (URGENT REPORT) The Science Behind the Orange Peel Trick for Metabolic Support

Indeterminate GlobeNewswire
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
January 5, 2026

Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock

Indeterminate GlobeNewswire
Galapagos Announces Board Decision to Initiate Wind-Down of Cell Therapy Activities
January 5, 2026

Galapagos Announces Board Decision to Initiate Wind-Down of Cell Therapy Activities

Indeterminate GlobeNewswire
Apogee Therapeutics to Host Conference Call to Report Interim Results from the Phase 1b Trial of APG777 in Patients with Mild-to-Moderate Asthma and 2026 Anticipated Milestones on January 6, 2026
January 5, 2026

Apogee Therapeutics to Host Conference Call to Report Interim Results from the Phase 1b Trial of APG777 in Patients with Mild-to-Moderate Asthma and 2026 Anticipated Milestones on January 6, 2026

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions